6.9
Agonistas adrenérgicos: Clasificación terapéutica
Los agonistas adrenérgicos pueden clasificarse según sus usos terapéuticos y mecanismos de acción. Sirven para diversos propósitos en aplicaciones clí…
Los agonistas adrenérgicos se clasifican en función de su mecanismo de acción, mientras que los simpaticomiméticos también se pueden clasificar por sus acciones terapéuticas.
Los agentes presores, o vasopresores, se utilizan para elevar la presión arterial baja. Estos incluyen catecolaminas endógenas, como la noradrenalina, y agentes sintéticos como la fenilefrina.
También sirven como estimulantes cardíacos al aumentar la frecuencia cardíaca, la fuerza de contractilidad y la velocidad de conducción.
Los broncodilatadores incluyen β 2-agonistas como el salbutamol y la terbutalina. Relajan los músculos pulmonares y ensanchan las vías respiratorias, lo que facilita la respiración.
α agonistas como la oximetazolina y la fenilefrina actúan como descongestionantes. Ayudan a aliviar la congestión nasal y despejan las narices obstruidas.
Los simpaticomiméticos no catecolaminas, como la anfetamina, actúan como estimulantes del SNC. Inducen inquietud, euforia e insomnio a través de la liberación de DA y serotonina.
β 2-agonistas como la ritodrina se usan para relajar el útero y retrasar el parto prematuro.
View the full transcript and gain access to JoVE Core videos
Q1: What are pressor agents and how do they work?
Pressor agents, or vasopressors, elevate low blood pressure and function as cardiac stimulants by increasing heart rate, force of contractility, and conduction velocity. Examples include endogenous catecholamines like noradrenaline and synthetic agents such as phenylephrine, making them essential for managing hypotensive conditions and supporting cardiovascular function.
Q2: How do beta-2 agonists relieve respiratory symptoms?
Beta-2 agonists like salbutamol and terbutaline relax bronchial muscles and widen airways, making breathing easier for patients with obstructive pulmonary disorders and asthma. These drugs reduce airway constriction and improve airflow by directly relaxing lung smooth muscle tissue through receptor activation.
Q3: What is the mechanism of action for decongestants?
Alpha-agonists like oxymetazoline and phenylephrine act as decongestants by constricting blood vessels in nasal tissues, reducing swelling and congestion. This vasoconstriction of the nasal mucosa helps relieve stuffy or blocked noses and sinuses by decreasing tissue edema and improving airflow through nasal passages.
Q4: How do indirect-acting CNS stimulants produce their effects?
Noncatecholamine sympathomimetics like amphetamine act as indirect-acting CNS stimulants by triggering the release of dopamine and serotonin rather than binding directly to receptors. These neurotransmitters induce restlessness, euphoria, and insomnia, distinguishing indirect-acting agents from direct-acting agents that bind adrenergic receptors.
Q5: What role do beta-2 agonists play in obstetrics?
Beta-2 agonists like ritodrine relax uterine smooth muscle and delay premature labor by reducing uterine contractions. By providing additional time for fetal development, these agents allow for interventions to improve maternal and fetal outcomes in at-risk pregnancies and support better neonatal health.
Q6: How are adrenergic agonists classified therapeutically?
Adrenergic agonists are classified based on their therapeutic actions and mechanisms of action. Major categories include vasopressors for blood pressure support, bronchodilators for airway relaxation, decongestants for nasal relief, CNS stimulants for neural effects, uterine relaxants for labor management, and beta-3 agonists for treating urinary incontinence.
Q7: What distinguishes catecholamine from noncatecholamine sympathomimetics?
Catecholamines like noradrenaline and dopamine are endogenous compounds that bind directly to adrenergic receptors, while noncatecholamine sympathomimetics like amphetamine lack the catechol moiety and work indirectly. Indirect agents trigger drugs affecting neurotransmitter release or uptake rather than direct receptor binding, producing different pharmacological profiles.